Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma (Q47611581)

4 February 2018

title

Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma (English)

1 reference

4 February 2018

author name string

Li Li

1

1 reference

4 February 2018

Ronghua Jin

2

1 reference

4 February 2018

Xiaoli Zhang

3

1 reference

4 February 2018

Fudong Lv

4

1 reference

4 February 2018

Lifeng Liu

5

1 reference

4 February 2018

Daojie Liu

6

1 reference

4 February 2018

Kai Liu

7

1 reference

4 February 2018

Ning Li

8

1 reference

4 February 2018

Dexi Chen

9

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 October 2012

1 reference

4 February 2018

published in

Hepatology

1 reference

4 February 2018

volume

56

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

1380-1390

1 reference

4 February 2018

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

cites work

1 reference

Global cancer statistics, 2002

21 January 2018

1 reference

Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma

21 January 2018

1 reference

Glypicans in growth control and cancer

21 January 2018

1 reference

The role of glypican-3 in the regulation of body size and cancer

21 January 2018

1 reference

Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function

21 January 2018

1 reference

Mechanism of transcriptional activation by the Myc oncoproteins

21 January 2018

1 reference

A large scale genetic analysis of c-Myc-regulated gene expression patterns

21 January 2018

1 reference

Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene

21 January 2018

1 reference

E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair

21 January 2018

1 reference

Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'-promoter and 3'-terminal ends of the human glypican 3 (GPC3) gene

21 January 2018

1 reference

Conditional transgenic models define how MYC initiates and maintains tumorigenesis

21 January 2018

1 reference

Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling

21 January 2018

1 reference

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2.

21 January 2018

1 reference

Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma

21 January 2018

1 reference

Activation of c-Ki-ras coexists with c-myc amplification in cells from a nude mouse tumor induced by the human breast carcinoma cell line SW 613-S.

21 January 2018

1 reference

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

21 January 2018

1 reference

Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas

21 January 2018

1 reference

Cancer gene discovery in hepatocellular carcinoma

21 January 2018

1 reference

21 January 2018

1 reference

Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin/TCF.

21 January 2018

1 reference

Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway

21 January 2018

1 reference

Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding

21 January 2018

1 reference

Live and let die in the intestinal epithelium

21 January 2018

1 reference

Linking colorectal cancer to Wnt signaling

21 January 2018

1 reference

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

21 January 2018

1 reference

B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver

21 January 2018

1 reference

High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma

21 January 2018

1 reference

Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Glypican-3 as a serum marker for hepatocellular carcinoma

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.25891

1 reference

4 February 2018

1 reference

4 February 2018